{"id":"W1990941062","doi":"10.2165/00063030-200822040-00005","title":"Anti-Adhesion Molecule Strategies for Crohn Disease","year":2008,"lang":"en","type":"review","venue":"BioDrugs","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":16,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Infliximab; Crohn's disease; Adalimumab; Medicine; Monoclonal antibody; Disease; Tumor necrosis factor alpha; Monoclonal antibody therapy; Inflammatory bowel disease; Immunology; Monoclonal; Certolizumab pegol; Antibody; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001008313,0.001168301,0.001777335,0.001460108,0.0003228145,0.001149826,0.001232547,0.001728251,0.002573634],"category_scores_gemma":[0.0007567662,0.0003704055,0.0005409007,0.001276155,0.0008545317,0.001473121,0.0006604642,0.003876613,0.001964705],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000744259,"about_ca_system_score_gemma":0.0006653335,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000780121,"about_ca_topic_score_gemma":0.00202128,"domain_scores_codex":[0.9998273,0.0000314666,0.00002146795,0.0000273667,0.00006725555,0.00002523941],"domain_scores_gemma":[0.9997255,0.0001380659,0.00003036935,0.00001010079,0.00006564906,0.00003023428],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002385719,0.0001832784,0.0001346136,0.006000093,0.0001021305,0.0004122588,0.00004661698,0.0009019214,0.004669979,0.008803548,0.06498958,0.9135175],"study_design_scores_gemma":[0.00009000883,0.0001321697,0.0003230936,0.0009532929,0.00008845716,0.0009270188,0.00003169995,0.0001746456,0.0008924371,0.002730405,0.9936407,0.0000159819],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0001651065,0.9971041,0.0004451521,0.0005033787,0.0006606504,0.000008528173,0.00001633911,0.0000137715,0.00108288],"genre_scores_gemma":[0.001087478,0.995659,0.000738359,0.0005408295,0.000451858,0.00002093335,0.00004250429,0.000003127398,0.001455981],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.002573634,"threshold_uncertainty_score":0.008609653,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02500131258589668,"score_gpt":0.3008105274606349,"score_spread":0.2758092148747383,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}